Symetrify ⚠ Under review

Under review — some data on this profile may be inaccurate and is being re-verified.

Revolutionizing the management and prevention of chronic lower back pain (CLBP) with a physio-adaptive wearable.

Health Tech & Life Sciences
Active
Seed Tel Aviv, Israel Founded 2022
Last updated 2026-07-20
Total raised
$1.0M
Last: Undisclosed Round 2022-02
Stage
Seed
Founded
2022
Headcount
2
HQ
Tel Aviv, Israel
Sector
Health Tech & Life Sciences

About

Symetrify aims to establish a new standard of care in the assessment and improvement of neuro-musculoskeletal health. Their proprietary technology platform, including the L-PACT wearable, assesses biomechanical faults of dynamic low back posture using AI sensing and applies automated counter-compressive force pressures to restore lumbo-pelvic balance. The company's go-to-market strategy targets the U.S. physical therapy and chiropractic market, followed by sports, fitness, and workplace wellness sectors. Symetrify's technology can also be applied to other neuromuscular conditions like neck pain, shoulder pain, and sports injuries.

Funding history · 1 round · $1.0M total

2022-01
Seed $1.0M
★ eHealth VenturesIsrael Innovation Authority

Headcount over time

From 6 (2022-06) to 1 (2026-01) · -5 (-83%) · 4 points · source: Finder history + radar grounding
60 2022-06 2026-01

Q&A

What is Symetrify's primary product?
Symetrify develops the L-PACT, a neuromechanical wearable training device designed for assessing, treating, and preventing spinal kinetic dysfunctions associated with chronic low back pain (CLBP).
When was Symetrify founded?
Symetrify was founded in February 2022.
How much funding has Symetrify raised to date?
Symetrify has raised a total of $1,000,000.
Which investors participated in Symetrify's funding round?
In February 2022, Symetrify received funding from eHealth Ventures and Israel Innovation Authority.
What is Symetrify's primary sector?
Symetrify operates in the Health Tech & Life Sciences sector.
What technologies does Symetrify utilize in its product?
Symetrify's technology is based on Artificial Intelligence, Platforms & Interfaces, and Software.
What is the target customer segment for Symetrify's product?
Symetrify targets customers in Healthcare & Life Sciences, specifically Healthcare Providers.

Team · 1

Dr. Ami Eyal
Founder · Founder, CMO & R&D

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligencePlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

Verified

Tags

wearablephysiotherapyalgorithmsautomationsoftware-applicationsdigital-healthcaretreatmentsdigital-therapeuticspersonalizationartificial-intelligencemedical-devicesreal-timenon-invasivechronic-painwearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitesymetrify.com
LinkedInlinkedin.com/company/88473049

Identifiers & details

Legal nameSYMMETRIUM LTD
Former namesSkelekinetics
Founded2022-2
Employees (exact)2

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainsymetrify.com

Certificate / subdomain footprint

Subdomains8

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516558004
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2022-02-09
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events4 — people (3), shares_capital (1)
Registered addressבראון 6 הרצליה

Recent registry events

DateEvent
2025-09-29עדכון דירקטורים-עדכון מנהלים
2025-09-29עדכון דירקטורים-הסרת דירקטור
2025-09-29עדכון דירקטורים-הוספת דירקטור
2026-01-05הקצאת מניות